Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
6618.HK Stock Summary
Top 10 Correlated ETFs
6618.HK
In the News
6618.HK Financial details
Company Rating
Buy
Market Cap
161.86B
Income
447.39M
Revenue
53.96B
Book val./share
-7.01
Cash/share
16.88
Dividend
-
Dividend %
-
Employees
2.74K
Optionable
No
Shortable
Yes
Earnings
23 Aug 2023
P/E
323.59
Forward P/E
-
PEG
-23.05
P/S
2.73
P/B
-6.6
P/C
3.02
P/FCF
21.81
Quick Ratio
2.85
Current Ratio
3.45
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.14
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
41.74%
Revenue Q/Q
2.58%
EPS Q/Q
2.47%
-
-
-
-
SMA20
-7.79%
SMA50
-16.74%
SMA100
-30.26%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-7%
ROC
-
Gross Margin
21%
Oper. Margin
-
Profit Margin
1%
Payout
-
Shs Outstand
3.18B
Shs Float
1.01B
-
-
-
-
Target Price
-
52W Range
39.3-90.75
52W High
-43.44%
52W Low
+30.51%
RSI
48.83
Rel Volume
1.12
Avg Volume
6.26M
Volume
7M
Perf Week
5.49%
Perf Month
-9.27%
Perf Quarter
-43%
Perf Half Y
-36.06%
-
-
-
-
Beta
0.542259
-
-
Volatility
0.94%, 2.67%
Prev Close
0.3%
Price
50.9
Change
-0.68%
6618.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.61 | 3.47 | 8.78 | 9.91 | 0 | |
Net income per share | 0.07 | -0.31 | -7.8 | -0.35 | 0 | |
Operating cash flow per share | 0.06 | 0.13 | 1.68 | 1.11 | 0 | |
Free cash flow per share | 0.06 | 0.13 | 1.66 | 0.94 | 0 | |
Cash per share | 0.01 | 2.03 | 18.25 | 13.57 | 0 | |
Book value per share | 0.24 | -0.15 | 17.77 | 12.88 | 0 | |
Tangible book value per share | 0.24 | -0.15 | 17.77 | 12.88 | 0 | |
Share holders equity per share | 0.24 | -0.15 | 17.77 | 12.88 | 0 | |
Interest debt per share | 0 | 0.01 | 0.04 | 0.07 | 0 | |
Market cap | 299.52B | 306.81B | 276.55B | 156.1B | 0 | |
Enterprise value | 299.51B | 301.85B | 244.37B | 139.05B | -21.18B | |
P/E ratio | 1.39K | -315.71 | -16.05 | -145.51 | 0 | |
Price to sales ratio | 36.67 | 28.3 | 14.27 | 5.09 | 0 | |
POCF ratio | 1.6K | 749.27 | 74.75 | 45.5 | 0 | |
PFCF ratio | 1.62K | 759.83 | 75.55 | 53.6 | 0 | |
P/B Ratio | 399.78 | -668.38 | 7.05 | 3.92 | 0 | |
PTB ratio | 399.78 | -668.38 | 7.05 | 3.92 | 0 | |
EV to sales | 36.66 | 27.84 | 12.61 | 4.53 | -0.45 | |
Enterprise value over EBITDA | 944.73 | -382.13 | -14.34 | -175.13 | -22.45 | |
EV to operating cash flow | 1.6K | 737.18 | 66.05 | 40.53 | -3.59 | |
EV to free cash flow | 1.62K | 747.56 | 66.75 | 47.74 | -5.83 | |
Earnings yield | 0 | 0 | -0.06 | -0.01 | 0 | |
Free cash flow yield | 0 | 0 | 0.01 | 0.02 | 0 | |
Debt to equity | 0 | -0.02 | 0 | 0.01 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | -0.04 | 6.27 | 1.89 | 21.48 | -22.45 | |
Current ratio | 2.71 | 5.58 | 9.12 | 5.71 | 3.45 | |
Interest coverage | 2.05K | -22.46 | -5K | -142.88 | 88.26 | |
Income quality | 0.87 | -0.42 | -0.21 | -3.2 | 15.41 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.13 | 0.12 | 0.13 | 0.18 | 0.05 | |
Research and developement to revenue | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.01 | -0.01 | -0.01 | -0.15 | -0.38 | |
Capex to revenue | 0 | 0 | 0 | -0.02 | -0.05 | |
Capex to depreciation | -0.39 | -0.77 | -1.42 | -8.2 | -16.16 | |
Stock based compensation to revenue | 0 | 0 | 0.02 | 0.08 | 0.05 | |
Graham number | 0.61 | 1.01 | 55.86 | 10.02 | 0 | |
ROIC | 0.27 | 0.55 | 0.73 | -0.13 | -0.01 | |
Return on tangible assets | 0.18 | -0.11 | -0.39 | -0.02 | -0.15 | |
Graham Net | 0.05 | -0.68 | 16.49 | 11.43 | 0 | |
Working capital | 735.82M | 7.08B | 38.02B | 37.7B | 45.37B | |
Tangible asset value | 746.46M | -459.63M | 39.22B | 39.83B | -21.23B | |
Net current asset value | 733.41M | -511.67M | 37.96B | 37.56B | 45.22B | |
Invested capital | 0 | -0.02 | 0 | 0.01 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 256.44M | 392.61M | 1.67B | 4.19B | 9.05B | |
Average inventory | 999.67M | 1.2B | 1.51B | 2.39B | 4.91B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 20.06 | 20.23 | 73.17 | 85.25 | 124.92 | |
Days of inventory on hand | 65.76 | 58.11 | 43.71 | 47.27 | 67.23 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 18.19 | 18.05 | 4.99 | 4.28 | 2.92 | |
Inventory turnover | 5.55 | 6.28 | 8.35 | 7.72 | 5.43 | |
ROE | 0.29 | 2.12 | -0.44 | -0.03 | -0.02 | |
Capex per share | 0 | 0 | -0.02 | -0.17 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-12-31 for Q4
Metric | History | 2021-12-31 | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 |
---|---|---|---|---|---|---|
Revenue per share | 2.48 | 3.91 | 3.71 | 4.67 | 4.79 | |
Net income per share | -0.09 | 0.04 | 0.04 | 0.03 | 0.03 | |
Operating cash flow per share | 0.28 | 0.44 | 0.41 | 0.64 | 0.66 | |
Free cash flow per share | 0.24 | 0.43 | 0.41 | 0.64 | 0.66 | |
Cash per share | 13.57 | 16.12 | 14.31 | 16.45 | 16.88 | |
Book value per share | 12.88 | -7.53 | 13.26 | -6.83 | -7.01 | |
Tangible book value per share | 12.88 | -4.07 | 13.26 | -6.61 | -6.78 | |
Share holders equity per share | 12.88 | -7.53 | 13.26 | -6.83 | -7.01 | |
Interest debt per share | 0.07 | -0.04 | 0.02 | -0.08 | -0.08 | |
Market cap | 156.1B | 124.58B | 167.64B | 127.91B | 199.14B | |
Enterprise value | 139.05B | 103.99B | 151.17B | 107.26B | 177.95B | |
P/E ratio | -145.51 | 226.15 | 321.01 | 361.69 | 548.93 | |
Price to sales ratio | 20.35 | 9.97 | 14.15 | 8.75 | 13.27 | |
POCF ratio | 182 | 89.4 | 126.89 | 63.54 | 96.44 | |
PFCF ratio | 214.38 | 90.25 | 128.11 | 63.87 | 96.94 | |
P/B Ratio | 3.92 | -5.18 | 3.96 | -5.98 | -9.08 | |
PTB ratio | 3.92 | -5.18 | 3.96 | -5.98 | -9.08 | |
EV to sales | 18.13 | 8.32 | 12.76 | 7.33 | 11.86 | |
Enterprise value over EBITDA | -700.53 | 1.68K | 2.58K | -1.21K | -1.95K | |
EV to operating cash flow | 162.12 | 74.62 | 114.42 | 53.28 | 86.18 | |
EV to free cash flow | 190.97 | 75.33 | 115.52 | 53.56 | 86.63 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0.01 | 0.01 | 0.02 | 0.01 | |
Debt to equity | 0.01 | 0 | 0 | 0 | 0 | |
Debt to assets | 0 | 0 | 0 | 0 | 0 | |
Net debt to EBITDA | 85.9 | -333.2 | -281.19 | 232.55 | 232.55 | |
Current ratio | 5.71 | 4.88 | 4.88 | 3.45 | 3.45 | |
Interest coverage | -227.65 | -0.67 | -0.67 | 0.29 | 0.29 | |
Income quality | -3.2 | 10.09 | 10.09 | 23.31 | 23.31 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.25 | 0.05 | 0.05 | 0.04 | 0.04 | |
Research and developement to revenue | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.15 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to revenue | -0.02 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -8.2 | -0.42 | -0.42 | -0.21 | -0.21 | |
Stock based compensation to revenue | 0.08 | 0.05 | 0.05 | 0.04 | 0.04 | |
Graham number | 5.01 | 2.7 | 3.49 | 2.08 | 2.14 | |
ROIC | -0.05 | 0 | 0 | 0 | 0 | |
Return on tangible assets | -0.01 | -5.65 | 0 | -0.04 | -0.04 | |
Graham Net | 11.43 | 12.76 | 11.59 | 11.7 | 12 | |
Working capital | 37.7B | 49.73B | 40.25B | 44.23B | 45.37B | |
Tangible asset value | 39.83B | -12.98B | 42.33B | -20.7B | -21.23B | |
Net current asset value | 37.56B | 49.57B | 40.12B | 44.08B | 45.22B | |
Invested capital | 0.01 | 0 | 0 | 0 | 0 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 3.43B | 7.41B | 8.2B | 9.68B | 12.45B | |
Average inventory | 1.9B | 3.76B | 4.05B | 5.12B | 6.7B | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 84.08 | 86.11 | 68.68 | 95.35 | 95.35 | |
Days of inventory on hand | 46.62 | 41.3 | 35.26 | 51.31 | 51.31 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 1.07 | 1.05 | 1.31 | 0.94 | 0.94 | |
Inventory turnover | 1.93 | 2.18 | 2.55 | 1.75 | 1.75 | |
ROE | -0.01 | -0.01 | 0 | 0 | 0 | |
Capex per share | -0.04 | 0 | 0 | 0 | 0 |
6618.HK Frequently Asked Questions
What is JD Health International Inc. stock symbol ?
JD Health International Inc. is a CN stock and trading under the symbol 6618.HK
What is JD Health International Inc. stock quote today ?
JD Health International Inc. stock price is $50.9 today.
Is JD Health International Inc. stock public?
Yes, JD Health International Inc. is a publicly traded company.